Late-breaking science announced for TVT 2019
CRF meeting covering the latest in structural heart disease will take place June 12-15 in Chicago WHAT: The Cardiovascular Research ...
CRF meeting covering the latest in structural heart disease will take place June 12-15 in Chicago WHAT: The Cardiovascular Research ...
Tim Reynolds, co-founder of Wall Street's Jane Street Capital, funds new avenue of research at the Center for Spinal Stimulation ...
Results from world first trial could influence treatment decisions for patients with oropharyngeal cancerCredit: Lawson Health Research Institute LONDON, ON ...
Combining an immunotherapy drug with two target therapies helps extend the lives of people with advanced melanoma Los Angeles - ...
Researchers received six grants totaling nearly $2.0 million to investigate novel ways to improve quality of life for individuals with ...
Immunotherapy used with chemotherapy or on its own is a better first-line treatment for people with head and neck cancer ...
1. Anonymous essay says sometimes 'choice' is a lie Impassioned author explains how extreme politics can warp patient care Abstract: ...
Researchers seek to break down HIV exclusions in cancer clinical trialsCredit: Robert Hood / Fred Hutch SEATTLE -- June 2, ...
The majority of women who underwent lumpectomy or mastectomy surgeries for breast cancer report that the scars from those surgeries ...
The Henry Ford Cancer Institute has earned a full three-year accreditation designation by the National Accreditation Program for Breast Centers ...
A pre-specified secondary analysis published today in the New England Journal of Medicine adds new information to the original TAILORx ...
Promising results that led to new $2.7 million NCI grant presented at ASCO annual meeting on June 2 CLEVELAND - ...
UCLA-led study evaluated use of drug combined with endocrine therapy in premenopausal womenCredit: UCLA Jonsson Comprehensive Cancer Center A UCLA-led ...
SALT LAKE CITY, UTAH - Today the New England Journal of Medicine published the first results of a phase III ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.